Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Nojunk]

Even something as modest as a $30 million partnership in the US and a $15 million deal in the EU would mean cash of $55 million or $3.20 cash per share fully diluted. Not taking into account even the value added by the nda, tyrnovo ind, possible renal results with subsequent likelihood of FDA approval, this is a joke of a market cap. I imagine the partnerships will be twice as large at the very least.